My first Publication Molecular Diagnostics Market by Product-converted

Molecular Diagnostics Market by Product & Services, Technique, End Users and Global
Region - Analysis & Forecast 2019-2030
Molecular Diagnostics Market Prominent Players
The prominent players in the global Molecular Diagnostics market are Abbott Laboratories, Agilent
Technologies, Thermo Fisher Scientific, Becton, Dickinson and Company, Illumina, QIAGEN N.V., Danaher
Corporation, Hologic, F. Hoffmann-La Roche, and Biomerieux SA., among others.
Companies are working on expanding their product portfolio to get a hold on the market
Vaarious key players are adopting strategies such as Mergers and Acquisitions (M&A) to increase their market
share. For instance, Hologic acquired Gen-Probe, to expand its product portfolio with focus on various types of
cancer’s diagnostics. Moreover, Cepheid launched GeneXpert Omni in 2015, which is the most portable
molecular diagnostics system in the world.
Some of the major players in the molecular diagnostics market include Bio-Rad Laboratories, Inc.; Bayer AG;
Siemens Healthcare GmbH; Abbott; Alere, Inc.; Danaher; Dickinson and Company; Dako; Hologic, Inc. (Gen
probe); Novartis AG; Sysmex Corporation; Qiagen N.V.; Johnson & Johnson; Becton, Roche Diagnostics;
bioMerieux SA; and Cepheid among others.
GET FREE SAMPLE- https://www.marketindustryreports.com/pdf/10
Molecular Diagnostics Market, By Technology
Sequencing technology segment is forecasted to witness 14.7% CAGR over the forecast period. Sequencing is
being widely used in molecular diagnosis of paediatric diseases such as Duchenne muscular dystrophy and
monogenic diabetes. Sanger sequencing is the choice of method for mutation screening, however next generation
sequencing (NGS) is rapidly being recognized as most efficient technology for detection and screening of genetic
variations. Targeted NGS offers better quality and simplified dataset analysis that will spur its demand in near
future.
Molecular Diagnostics Market, By Region
Germany molecular diagnostics market accounted for USD 426.1 million is 2017. Germany currently dominates
the European molecular diagnostic industry and scenario is likely to remain so in near future. Increasing
incidences of lifestyle and infectious diseases coupled with favourable demographic trends such as aging
population will drive the industry growth. Robust research and development in molecular diagnostic field and
high awareness regarding the benefits of early diagnosis will expand the molecular diagnostics market growth
in Germany.
Key questions answered in the report include
•
•
•
•
•
What will the market size and the growth rate be in 2021?
What are the key factors driving the global POC molecular diagnostics market?
What are the key market trends impacting the growth of the global POC molecular diagnostics market?
What are the challenges to market growth?
Who are the key vendors in the global POC molecular diagnostics market?